Antimicrobial drug resistance in Singapore hospitals

Emerging Infectious Diseases

Volumn 13, Issue 12, 2007, Pages 1944-1947

  Hsu, Li Yang ^a,g   Tan, Thean Yen ^b   Jureen, Roland ^c   Koh, Tse Hsien ^d   Krishnan, Prabha ^e   Lin, Raymond Tzer Pin ^a   Tee, Nancy Wen Sin ^f   Tambyah, Paul Ananth ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b CHANGI GENERAL HOSPITAL   (Singapore)

^c ALEXANDRA HOSPITAL   (Singapore)

^d SINGAPORE GENERAL HOSPITAL   (Singapore)

^e TAN TOCK SENG HOSPITAL   (Singapore)

^f KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^g Dept Medicine Endocrinol Diabet   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; CARBAPENEM; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; IMIPENEM; MACROLIDE; METICILLIN; POLYMYXIN; QUINOLONE; SULTAMICILLIN; VANCOMYCIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; ENTEROCOCCUS; ESCHERICHIA COLI; HEALTH PROGRAM; HEALTH SURVEY; HOSPITAL; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; PSEUDOMONAS AERUGINOSA; SINGAPORE;

EID: 37149040172     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1312.070299     Document Type: Article

References (12)

1. Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE Jr. Trends in antimicrobial drug development: implications for the future. Clin Infect Dis. 2004;38:1279-86.
2. Talbot GH, Bradley J, Edwards JE Jr, Gilbert D, Scheld M, Bartlett JG, et al. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis. 2006;42:657-68.
3. Simonsen GS, Tapsall JW, Allegranzi B, Talbot EA, Lazzari S. The antimicrobial resistance containment and surveillance approach - a public health tool. Bull World Health Organ. 2004;82:928-34.
4. Australian Group on Antimicrobial Resistance (AGAR) [cited 2007 Feb 10]. Available from http://www.antimicrobial-resistance.com
5. European Antimicrobial Resistance Surveillance System (EARSS) [cited 2007 Feb 10]. Available from http://www.rivm.nl/earss
6. Ministry of Health. Singapore. Health Facilities [cited 2007 Feb 10]. Available from http://www.moh.gov.sg/mohcorp/statistics.aspx?id=5964
7. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Supplement M100-S14, Vol 24(1). Wayne (PA): The Institute; 2005.
8. Bell SM, Gatus BJ, Pham JN, Rafferty DL. Antibiotic susceptibility testing by the CDS method. A manual for medical and veterinary laboratories. Randwick (Australia): The Antibiotic Reference Laboratory Services, South Eastern Area Laboratory Services; 2005.
9. Clinical Laboratory Standards Institute. Analysis and presentation of cumulative susceptibility test data; approved guideline - 2nd ed. Document M39-A2. Vol 25(28). Wayne (PA): The Institute; 2006.
10. Hirakata Y, Matsuda J, Miyazaki Y, Kamihira S, Kawakami S, Miyazawa Y, et al. Regional variation in the prevalence of extendedspectrum beta-lactamse-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). Diagn Microbiol Infect Dis. 2005;52:323-9.
11. Song JH, Hiramatsu K, Suh JY, Ko KS, Ito T, Kapi M, et al. Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin. Antimicrob Agents Chemother. 2004;48:4926-8.
12. Koh TH, Sng LH, Wang GC, Hsu LY, Zhao Y. IMP-4 and OXA betalactamases in Acinetobacter baumannii from Singapore. J Antimicrob Chemother. 2007;59:627-32. 1948-1950